IP Group’s FY24 Results: From NAV Theory to Real-World Exits

Disclaimer: This article is sponsored by IP Group.

This article is for informational purposes only, it should not be considered financial advice. Investing in early stage venture involves substantial risk. Always consult a qualified financial advisor before making any investment decisions. Full disclaimers below.

In yesterday’s article, we unpacked how to read and analyse venture-style listed investment companies like IP Group — and why Net Asset Value (NAV), not earnings, is the true signal. Today, IP Group’s full-year results for 2024 landed, and they offer a textbook case study of the principles we laid out.

Haven’t read part one? Check it out here — it’s your guide for decoding investment vehicles that play in the high-stakes world of science, innovation, and venture capital.

Now, let’s take that theory for a spin and walk through what IP Group’s FY24 numbers really tell us.

NAV Dropped, But the Exit Machine Was Roaring

IP Group reported a 15% drop in NAV per share to 97.7p, down from 114.8p at the end of 2023. Total NAV came in at £952.5 million, compared to £1.19 billion the year before.

That sounds tough, right? But here’s where understanding venture-style metrics pays off.

Behind the headline NAV drop was a record year for exits. Cash proceeds from realisations hit £183.4 million — a massive 375% increase from 2023. It was the most active exit year in the company’s history, led by:

£134m from the sale of Featurespace to Visa – the Group’s largest ever exit
£30m from the sale of Garrison Technology to Everfox
£9.2m from the sale of Kynos Therapeutics to Dr Falk Pharma
Up to £15m from secondary sales in six portfolio companies, all at a small premium to NAV

That’s what success looks like in this game: turning paper valuations into cash.

Why NAV Fell Despite Record Exits

NAV per share took a hit mainly due to mark-downs in three key areas:

Oxford Nanopore Technologies (ONT): Market value declined, reducing the fair value of IP Group’s largest listed holding
Istesso: Despite promising data on secondary endpoints, its Phase 2b trial didn’t meet its primary endpoint
First Light Fusion: Repositioned business model and revalued in line with market conditions

In a venture portfolio, where valuations move with sentiment and science milestones, this volatility is part of the deal. Exits create tangible wins, while valuation shifts affect NAV.

A Strengthened Balance Sheet and Buyback Firepower

IP Group now has £285.6 million in gross cash and deposits, up 26% year-on-year. That’s a lot of dry powder — not just for new deals, but for capital returns.

The Group completed £30 million of share buybacks in 2024 and is on track to hit £80 million. Over 10% of share capital has already been retired, and this morning they announced:

A further £10 million extension to the programme
A new policy to allocate 50% of 2025 exit proceeds to buybacks

If you’re tracking NAV discounts, this is huge. It’s one of the clearest signals yet that IP Group sees its shares as undervalued — and is willing to back that view with capital.

Capital Deployment: Disciplined, But Active

IP Group invested £63 million across 38 companies in FY24, with a strong focus on existing winners and capital-efficient bets. Highlights include:

Hysata: Completed a $111m Series B — the largest cleantech Series B in Australian history
Genomics and Enterprise Therapeutics: Closed major funding rounds
4 companies (Storm, Mission, Kynos, Abliva): Reported positive clinical trial data
AI computing plays like Instrisic and Lumai: Noted as areas of strong third-party interest

The portfolio is showing momentum in both life sciences and deeptech, even as the wider venture market remains subdued.

Overhead Cuts: Running Leaner

One subtle but important shift — total net overheads fell by 12%, with the run rate cut by 23% by year-end. That matters because internal costs directly impact NAV.

For long-term investors, it signals discipline: this is a team managing capital with a sharper focus.

Looking Ahead: IPO Pipelines and 2025 Goals

There are some juicy post-period updates too:

Hinge Health has filed for a New York IPO, potentially creating another major liquidity event
IP Group reaffirmed confidence in delivering £250m+ of exits from private companies by 2027
Cash position remains strong at £277 million as of March 21, with an additional £24.7 million of proceeds already banked this year

NAV volatility might grab headlines, but this pipeline shows the real story is far from over.

Final Thoughts: This Is the Playbook in Action

IP Group’s FY24 results are a near-perfect case study of the mechanics we broke down yesterday. Here’s what we’re seeing:

NAV fell, but that’s not the full story
Cash exits were the strongest in company history
Balance sheet strength enables further share buybacks
Portfolio discipline is yielding results, even in a tough macro backdrop

If you’re analysing listed venture-style companies, this is what it looks like when the strategy starts to mature. The NAV might wobble quarter-to-quarter — but cash can tell its own story.

To stay plugged in on IP Group and other venture-stage investment vehicles, visit www.curationconnect.com. You’ll find deeper insights, curated data, and real-time updates on where NAV, exits, and innovation intersect.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research or consult a financial advisor before making investment decisions.

‍

Disclaimer information
Curation Connect is an information service provided by Curation Corporation. General disclaimer and copyright This briefing has been commissioned by IP Group and prepared and issued by Curation Connect, in consideration of a fee payable by IP Group. Fees are paid upfront in cash without recourse. Curation may seek additional fees for the provision of related IR services for the client but does not get remunerated for any investment banking services. We do not take payment in stock, options or warrants for any of our services. Liability Your investments are your responsibility. No liability whatsoever is accepted by Curation Corporation Limited or any Curation Corporation company of their respective directors, officers, employees or analysts for any loss, whether direct, indirect, special, incidental or consequential, arising whether directly or indirectly as a result of the recipient acting or not acting on any information in any Curation Connect publication, including, without limitation, lost profits arising from the use of the Curation Connect service or any of its publications. We have no liability for any loss of profit, loss of revenue, loss of business, business interruption, loss of opportunity or any indirect, special or consequential loss; any losses which arise from any event beyond our reasonable control; any losses which could not reasonably have been anticipated; or your inability to access and/or use the Curation Connect service or the website. We do not exclude or limit in any way our liability to you where it would be unlawful to do so. Disclaimer Curation Connect publications are provided for general information purposes only and should not be regarded as an offer, solicitation, invitation, inducement or recommendation relating to the subscription, purchase or sale of any security or other financial instrument or investment. This report is intended only for investors who are 'professional clients' as defined by the FCA, and may not, therefore, be redistributed to other classes of investors. This document is provided for information purposes only and should not be regarded as an offer, solicitation, invitation, inducement or recommendation relating to the subscription, purchase or sale of any security or other financial instrument. This document does not constitute, and should not be interpreted as, investment advice. You must carry out your own independent research and obtain suitable professional advice before making any investment decision. The Curation Connect publications do not take the specific needs, investment objectives and financial situation of any particular individual into consideration and we cannot state whether any investment mentioned is suitable for you. You should not base any investment decision solely on the basis of the information we publish or provide to you. Always be aware of market risks – never invest money you cannot afford to lose. All investments can go down as well as up. Investing in securities entails risks. Potential Conflicts of Interest Curation Connect or its respective directors, officers, employees, contributors and clients may have or take positions in the securities, entities or investments mentioned in the Curation Connect publications. Any of these circumstances could create, or be perceived as creating, conflicts of interest. Privacy and Registration All information received from you and your use of the Curation Connect service and the website will be used by Curation Corporation Limited in accordance with our Privacy Policy. Please read this for details of how we may process your personal data. On registration for the Curation Connect service, you must provide us with accurate, complete registration information and it is your responsibility to update and maintain changes to your information. Curation Connect, a trading name of Curation Corporation Limited, is entitled to rely on any information you provide to us. Read our full T&Cs, disclaimers and privacy notice. Contact us at info@curationcorp.com Curation Corporation Limited, 58 Borough High Street, London, SE1 1XF, UK